Sermorelin mastery course
Unit 10 of 11
Administration and the regulatory landscape
Sermorelin sits in an unusual legal space: a formerly approved drug that now reaches patients almost entirely through c…
A compounded peptide in a shifting regulatory world
Sermorelin sits in an unusual legal space: a formerly approved drug that now reaches patients almost entirely through compounding pharmacies. Understanding that status is essential to reading claims about it honestly.
This unit explains the 503A compounding pathway, the regulatory arc that put sermorelin there, the product-variability that compounding creates, and the anti-doping status that matters for any athlete.